XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property and other revenues        
Resident fee income $ 11,839,000 $ 10,958,000 $ 23,689,000 $ 21,713,000
Rental income 38,568,000 34,277,000 75,567,000 66,836,000
Other revenue 1,096,000 139,000 1,815,000 157,000
Total property and other revenues 51,503,000 45,374,000 101,071,000 88,706,000
Expenses        
Property operating expenses 35,026,000 33,230,000 70,103,000 66,124,000
Interest expense 11,534,000 10,554,000 22,893,000 20,863,000
Transaction costs 0 0 97,000 0
Asset management fees - related party 0 2,457,000 0 5,104,000
General and administrative expenses 3,593,000 3,755,000 7,503,000 7,441,000
Depreciation and amortization 9,808,000 9,540,000 19,457,000 19,463,000
Impairment loss 43,422,000 13,002,000 43,422,000 13,002,000
Total expenses 103,383,000 72,538,000 163,475,000 131,997,000
Other income (loss)        
Other income, net 70,000 5,000 202,000 77,000
Realized gain (loss) on investments and other (4,647,000) (252,000) (4,315,000) 335,000
Income (loss) before equity in earnings (losses) of unconsolidated ventures and income tax expense (56,457,000) (27,411,000) (66,517,000) (42,879,000)
Equity in earnings (losses) of unconsolidated ventures (2,546,000) 34,053,000 (6,468,000) 36,555,000
Income tax expense (11,000) (15,000) (26,000) (30,000)
Net income (loss) (59,014,000) 6,627,000 (73,011,000) (6,354,000)
Net (income) loss attributable to non-controlling interests 1,233,000 180,000 1,304,000 225,000
Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders (57,781,000) 6,807,000 (71,707,000) (6,129,000)
Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders $ (57,781,000) $ 6,807,000 $ (71,707,000) $ (6,129,000)
Net income (loss) per share of common stock, basic (in dollars per share) [1] $ (0.30) $ 0.04 $ (0.37) $ (0.03)
Net income (loss) per share of common stock, diluted (in dollars per share) [1] $ (0.30) $ 0.04 $ (0.37) $ (0.03)
Weighted average number of shares of common stock outstanding, basic (in shares) [1] 193,156,094 194,044,709 194,282,546 193,708,466
Weighted average number of shares of common stock outstanding, diluted (in shares) [1] 193,156,094 194,044,709 194,282,546 193,708,466
Distributions declared per share of common stock (in dollars per share) $ 0 $ 0.50 $ 0 $ 0.50
[1] The Company issued 203,742 and 116,712 restricted stock units as of June 30, 2023 and June 30, 2022, respectively. The restricted stock units have been excluded from the diluted earnings per share calculation as their impact is anti-dilutive due to the net loss generated during the three and six months ended June 30, 2023 and the six months ended June 30, 2022. The impact of the restricted stock units on the diluted earnings per share calculation is de minimis for the three months ended June 30, 2022.